Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Omada Health, Inc.
Bear Case (25th pct.)
-61.1% vs price
Base Case (Median)
-48.6% vs price
Bull Case (75th pct.)
-28.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.80 | -86.2% | High (40%) |
| PE Comparable | $24.03 | 17.9% | Medium (25%) |
| Graham Number | $9.63 | -52.7% | Medium (40%) |
| EV/FCF | $11.34 | -44.4% | Medium (20%) |
Based on 4 out of 7 methods, OMDA appears overvalued at the current price of $20.37. The base case fair value of $10.48 implies 48.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.